Bronstein, Gewirtz & Grossman, LLC Reminds Aurinia Pharmaceuticals Inc. Investors of Class Action and Encourages Investors to Contact the Firm Pharmaceutical Investing
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm Market News
Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for AbbVie, Inc. Investors in Securities Fraud Class Action Lawsuit Pharmaceutical Investing
Gilead and Dragonfly Announce Strategic Research Collaboration to Develop Natural Killer Cell Engagers in Oncology and Inflammation Pharmaceutical Investing
BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference Pharmaceutical Investing
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
ABBV CLASS ACTION: Kessler Topaz Meltzer & Check, LLP Reminds AbbVie, Inc. Shareholders of Securities Fraud Class Action Lawsuit Pharmaceutical Investing
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm Market News
BriaCell Therapeutics: Developing Personalized Off-The-Shelf Immunotherapy Treatments for Cancer Patients Biotech Investing
RINVOQ® Approved by U.S. FDA as an Oral Treatment for Adults with Active Ankylosing Spondylitis Pharmaceutical Investing
